INVITRO AND INVIVO EVALUATION OF SUSTAINED-RELEASE SUSPENSIONS OF IBUPROFEN

被引:35
作者
DALAL, PS [1 ]
NARURKAR, MM [1 ]
机构
[1] NE LOUISIANA UNIV,SCH PHARM,DIV PHARMACEUT & MED CHEM,MONROE,LA 71209
关键词
MICROSPHERE; IBUPROFEN; SUSPENSION; REDISPERSIBILITY; SUSTAINED RELEASE; ULCEROGENICITY;
D O I
10.1016/0378-5173(91)90039-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to develop and evaluate suspensions of ibuprofen-loaded microspheres. The microspheres were prepared with cellulose acetate butyrate (CAB) and cellulose propionate (low molecular weight) (CPL) polymers with 1:2 and 1:3 drug loadings, respectively. To ensure minimum drug release from the microspheres into the suspension, the pH was buffered at 3.5. 0.5% w/v methylcellulose served as the suspending agent. Redispersibility and content uniformity studies carried out during a period of 6 months produced no evidence of a non-dispersible sediment and allowed for a uniform dose withdrawal. The suspensions were able to produce sustained ibuprofen blood levels and decrease gastrointestinal mucosal injury as compared to the free ibuprofen suspension. The suspension of CAB microspheres sustained ibuprofen blood levels for the longest time and produced least gastrointestinal mucosal damage.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 13 条
[1]   PREPARATION AND CHARACTERIZATION OF MICROOSPHERES CONTAINING THE ANTI-INFLAMMATORY AGENTS, INDOMETHACIN, IBUPROFEN, AND KETOPROFEN [J].
BODMEIER, R ;
CHEN, H .
JOURNAL OF CONTROLLED RELEASE, 1989, 10 (02) :167-175
[2]   THE PREPARATION AND EVALUATION OF DRUG-CONTAINING POLY(DL-LACTIDE) MICROSPHERES FORMED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
PHARMACEUTICAL RESEARCH, 1987, 4 (06) :465-471
[3]  
CHANG R-K, 1986, Pharmaceutical Technology, V10, P32
[4]   ROLE OF DIRECT TISSUE CONTACT IN THE PRODUCTION OF GASTRO-INTESTINAL ULCERS BY ANTI-INFLAMMATORY DRUGS IN RATS [J].
CIOLI, V ;
ROSSI, V ;
PUTZOLU, S ;
BARCELLONA, PS ;
CORRADINO, C .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 50 (02) :283-289
[5]   A TOXICOLOGICAL AND PHARMACOLOGICAL STUDY OF IBUPROFEN GUAIACOL ESTER (AF-2259) IN THE RAT [J].
CIOLI, V ;
PUTZOLU, S ;
ROSSI, V ;
CORRADINO, C .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 54 (02) :332-339
[6]  
DEASY PB, 1984, MICROENCAPSULATION R, P1
[7]   PHYSICAL STABILITY OF SULFAGUANIDINE SUSPENSIONS [J].
JONES, RDC ;
MATTHEWS, BA ;
RHODES, CT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1970, 59 (04) :518-&
[8]   PREPARATION OF CONTROLLED-RELEASE MICROSPHERES OF IBUPROFEN WITH ACRYLIC POLYMERS BY A NOVEL QUASI-EMULSION SOLVENT DIFFUSION METHOD [J].
KAWASHIMA, Y ;
NIWA, T ;
HANDA, T ;
TAKEUCHI, H ;
IWAMOTO, T ;
ITOH, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (01) :68-72
[9]  
KONDO A, 1979, MICROCAPSULE PROCESS, P16
[10]   RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF IBUPROFEN IN HUMAN-PLASMA [J].
LALANDE, M ;
WILSON, DL ;
MCGILVERAY, IJ .
JOURNAL OF CHROMATOGRAPHY, 1986, 377 :410-414